• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Periodontitis in patients with diabetes and its association with diabetes-related complication

byPaary BalakumarandAlex Chan
July 10, 2024
in Chronic Disease, Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Periodontitis has a strong association with Type 2 Diabetes and is exacerbated by poor glycemic control.

2. Type 1 Diabetes and periodontitis are only associated in patient subgroups with poor glycemic control

3. Periodontitis confers an increased risk for retinopathy and albuminuria in both Type 1 and Type 2 Diabetes. 

Evidence Rating Level: 3 (Average)

Periodontitis is an oral disorder comprised of soft tissue inflammation, loss of periodontal attachment, and potentially tooth loss which affects about 10% of adults worldwide. Observational studies have linked periodontitis with type 2 diabetes (T2D) and show a potential link to diabetes-related complications. This retrospective study aimed to look at the association between diabetes and periodontitis on a population level using multiple Swedish national registers. The occurrence of periodontitis and tooth loss (registered extractions regardless of reason) were assessed. Periodontitis was defined if ≥3 teeth with probing depths of ≥6 mm were determined by dental professionals. Hemoglobin A1c levels were used to describe glycemic control. Periodontitis was more common in T1D and T2D than in the control groups. There was a higher association between periodontitis and T2D. Poor glycemic control was associated with an increase in risk of periodontitis by up to 67% in T1D and up to 172% in T2D. Participants with good glycemic control had lower risk of periodontitis in T1D but not T2D. Glycemic control was also associated with risk for tooth loss in T1D and T2D. Overall, there is an association between T2D and periodontitis which is stronger at a younger age and is exacerbated by poor glycemic control. T1D only confers an additional risk of periodontitis in patients with poor glycemic control. Periodontitis was also correlated with diabetes-related complications including retinopathy and nephropathy (albuminuria) but not major events ischemic events such as ischemic heart disease and stroke. 

Click to read the study in BMJ

RELATED REPORTS

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

Aficamten is superior to metoprolol in the management of obstructive hypertrophic cardiomyopathy

Limiting antihypertensive use does not reduce mortality in nursing home residents with frailty

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseasediabetesendocrinologyinfectious diseases
Previous Post

#VisualAbstract: Amivantamab plus Lazertinib Improves Outcomes in Previously Untreated EGFR-Mutated Advanced NSCLC

Next Post

#VisualAbstract: Liberal Transfusion Strategy in Patients with Traumatic Brain Injury Does Not Change Outcomes

RelatedReports

β-blockers linked to improved survival in preserved ejection fraction heart failure
Cardiology

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

October 15, 2025
Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)
Cardiology

Aficamten is superior to metoprolol in the management of obstructive hypertrophic cardiomyopathy

October 14, 2025
Cardiology

Limiting antihypertensive use does not reduce mortality in nursing home residents with frailty

October 14, 2025
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Digitoxin improves outcomes in heart failure with reduced ejection fraction

October 14, 2025
Next Post
#VisualAbstract: Liberal Transfusion Strategy in Patients with Traumatic Brain Injury Does Not Change Outcomes

#VisualAbstract: Liberal Transfusion Strategy in Patients with Traumatic Brain Injury Does Not Change Outcomes

American Academy of Pediatrics recommends standards for adverse event disclosures

Poor cardiovascular health is a risk factor for female infertility

#VisualAbstract: Finotonlimab with chemotherapy increases overall survival in recurrent or metastatic head and neck cancer

#VisualAbstract: Finotonlimab with chemotherapy increases overall survival in recurrent or metastatic head and neck cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial
  • Work effort and time expenditure of primary care physicians
  • Increasing cancer incidence rates in younger and older adults worldwide
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.